{"id":36474,"date":"2025-08-01T16:53:06","date_gmt":"2025-08-01T13:53:06","guid":{"rendered":"https:\/\/massivebio.com\/?p=36474"},"modified":"2025-09-22T09:51:27","modified_gmt":"2025-09-22T06:51:27","slug":"how-is-myelofibrosis-diagnosed-a-step-by-step-guide","status":"publish","type":"post","link":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/","title":{"rendered":"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><span style=\"font-weight: 400;\">Myelofibrosis is a rare condition where the bone marrow&#8217;s capacity to produce blood cells is compromised. Its symptoms; such as fatigue, anemia, and enlarged spleen; can mimic other illnesses, making diagnosis particularly challenging. That\u2019s why understanding <\/span><a href=\"https:\/\/massivebio.com\/primary-myelofibrosis-causes-symptoms\/\"><span style=\"font-weight: 400;\">myelofibrosis; treatment, prevention &amp; management<\/span><\/a><span style=\"font-weight: 400;\"> is essential for timely and accurate care.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This guide provides a step-by-step breakdown of the myelofibrosis diagnosis process, including key tests, <\/span><b>myelofibrosis diagnostic criteria<\/b><span style=\"font-weight: 400;\">, and how <\/span><a href=\"https:\/\/massivebio.com\/physicians\/\"><span style=\"font-weight: 400;\">physicians <\/span><\/a><span style=\"font-weight: 400;\">distinguish it from similar blood conditions.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What Symptoms Typically Lead to Myelofibrosis Testing?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Persistent fatigue, bruising, or spleen-related discomfort often prompt testing. The journey toward an <\/span><b>MF diagnosis<\/b><span style=\"font-weight: 400;\"> usually begins with general symptoms that prompt further testing. These symptoms can be vague at first but may include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Persistent fatigue<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Easy bruising or bleeding<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Night sweats<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Bone pain<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Unexplained weight loss<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Abdominal discomfort due to spleen enlargement<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Some individuals are diagnosed after routine blood work flags an abnormality-often a complete blood count (CBC) showing anemia, elevated or low platelets, or unusual white blood cell counts.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">When these red flags appear, physicians begin the process of <\/span><b>myelofibrosis differential diagnosis<\/b><span style=\"font-weight: 400;\">-ruling out other conditions such as anemia of chronic disease, leukemia, or other myeloproliferative neoplasms (MPNs) like polycythemia vera (PV) or essential thrombocythemia (ET).<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Why Are Blood Tests the First Step in Diagnosing Myelofibrosis?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">They reveal abnormal blood cell levels and guide further diagnostic evaluation. Blood tests are the first tools used in identifying myelofibrosis, and they play a central role in narrowing down the cause of symptoms.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Myelofibrosis Blood Test<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The following laboratory tests are typically ordered:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Complete blood count (CBC): May reveal low red blood cell count (anemia), abnormally high or low white blood cells, or fluctuating platelet levels.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Peripheral blood smear: Shows teardrop-shaped red blood cells, immature white cells, or other abnormal cells that suggest bone marrow stress or fibrosis.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lactate dehydrogenase (LDH): Elevated levels may indicate cell turnover or destruction.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Erythropoietin level: Low levels may rule out secondary causes of anemia.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Iron studies, vitamin B12, folate levels: Help rule out nutritional causes of blood abnormalities.<\/span><\/li>\n<\/ul>\n<h3><b>Myelofibrosis Blood Test Results<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Abnormalities in blood test results do not confirm MF on their own but provide strong indicators when combined with other findings. For example:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Primary myelofibrosis blood test results <\/b><span style=\"font-weight: 400;\">often show:<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Moderate to severe anemia<\/span><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Elevated white blood cells (initially)<\/span><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Low platelet counts as disease progresses<\/span><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Abnormal immature blood cells (leukoerythroblastic picture)<\/span><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">These findings typically lead to a bone marrow biopsy, the gold standard for confirmation.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What Role Do Bone Marrow Biopsy and Genetic Testing Play in Diagnosing Myelofibrosis?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">They provide definitive evidence of disease presence, type, and underlying genetic mutations.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Myelofibrosis Bone Marrow Biopsy<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The next and most definitive diagnostic step is a bone marrow biopsy. This procedure removes a small sample of marrow-usually from the hip bone-for microscopic analysis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Here\u2019s what doctors look for in <\/span><b>myelofibrosis bone marrow biopsy<\/b><span style=\"font-weight: 400;\"> samples:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Fibrosis (scarring) in the bone marrow<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Atypical megakaryocytes (large, abnormal platelet-producing cells)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Reduced fat and hematopoietic cells<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Abnormal cell clusters or disorganization of marrow structure<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">A biopsy can also confirm whether the condition is primary or secondary (e.g., evolving from PV or ET).<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Genetic and Molecular Testing<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Following the biopsy, molecular tests are conducted to identify mutations associated with MF, such as:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">JAK2 V617F mutation<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">CALR mutation<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">MPL mutation<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">These mutations are present in roughly 90% of patients with primary myelofibrosis and help solidify the diagnosis. Their presence or absence may also guide treatment decisions and prognosis.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">How Do Doctors Confirm a Myelofibrosis Diagnosis?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">They rely on defined diagnostic criteria that vary slightly between primary and secondary forms. To officially confirm the disease, physicians use specific <\/span><b>myelofibrosis diagnosis criteria<\/b><span style=\"font-weight: 400;\">, which differ slightly depending on whether the MF is primary or secondary.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Myelofibrosis Diagnostic Criteria (WHO 2016)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The World Health Organization (WHO) outlines that diagnosing primary myelofibrosis requires meeting all three major criteria along with at least one minor criterion.<\/span><\/p>\n<h4><span style=\"font-weight: 400;\">Major Criteria:<\/span><\/h4>\n<p><span style=\"font-weight: 400;\">Bone marrow fibrosis of grade 2 or 3<\/span><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Presence of JAK2, CALR, MPL mutation, or other clonal marker<\/span><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Exclusion of other myeloid malignancies like CML, MDS, or PV<\/span><span style=\"font-weight: 400;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<h4><span style=\"font-weight: 400;\">Minor Criteria (any one of the following):<\/span><\/h4>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Anemia not due to other causes<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Leukocytosis (WBC &gt; 11 x 10\u2079\/L)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Palpable splenomegaly<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Elevated LDH<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Leukoerythroblastosis (immature cells in peripheral blood)<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Primary Myelofibrosis Diagnosis<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A patient meeting the above conditions with no history of ET or PV is classified as having primary myelofibrosis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This classification matters, as <\/span><b>primary myelofibrosis diagnosis <\/b><span style=\"font-weight: 400;\">often carries a different prognosis and treatment approach than secondary MF, which emerges from prior MPNs.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">How Is Myelofibrosis Risk Assessed and Monitored After Diagnosis?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Doctors use risk scoring systems to evaluate disease severity and guide treatment planning. Once MF diagnosis is established, doctors determine the disease risk level using scoring systems such as:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">DIPSS (Dynamic International Prognostic Scoring System)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">IPSS (International Prognostic Scoring System)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">MIPSS70+ (Mutation-Enhanced International Prognostic System)<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">These systems take into account age, symptoms, genetic markers, blood test results, and more to determine whether a patient falls into low, intermediate, or high-risk categories.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Imaging and Additional Tests<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">To further assess disease progression, physicians may recommend:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Ultrasound or MRI for spleen size<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">CT scans to assess organ involvement<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Cytogenetic analysis for chromosomal abnormalities<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Periodic blood and bone marrow tests to monitor changes over time<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Diagnosing myelofibrosis is a multi-step process requiring careful attention to blood markers, bone marrow characteristics, and genetic mutations. The key to early and accurate detection lies in knowing what to test-and when.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">To summarize:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The question, <\/span><b>\u201cHow is myelofibrosis diagnosed?\u201d<\/b><span style=\"font-weight: 400;\"> is important. Diagnosis involves a combination of blood tests, bone marrow biopsy, genetic analysis, and evaluation based on WHO <\/span><b>primary myelofibrosis diagnosis criteria.<br \/>\n<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Understanding <\/span><b>&#8220;How is primary myelofibrosis diagnosed?&#8221;<\/b><span style=\"font-weight: 400;\"> is crucial. By confirming marrow fibrosis, presence of driver mutations, and exclusion of secondary causes.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">What do <\/span><b>myelofibrosis blood test<\/b> <b>results<\/b><span style=\"font-weight: 400;\"> show? Typically anemia, abnormal blood counts, and elevated LDH.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Why is bone marrow biopsy essential? It confirms the degree of fibrosis and abnormal marrow architecture.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">What is the myelofibrosis differential diagnosis? Conditions like PV, ET, MDS, CML, and anemia-related disorders must be ruled out.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">If you or a loved one is navigating the <\/span><a href=\"https:\/\/massivebio.com\/primary-myelofibrosis-causes-symptoms\/\"><span style=\"font-weight: 400;\">primary myelofibrosis; causes, symptoms<\/span><\/a><span style=\"font-weight: 400;\">, and diagnosis process, staying informed about the steps, criteria, and significance of each test can empower you to ask the right questions and participate fully in treatment planning. Massive Bio delivers hope through innovative, personalized, and accessible cancer care at every stage.<\/span><\/p>\n<p><a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/myelofibrosis\/diagnosis-treatment\/drc-20355062#:~:text=Blood%20tests,-A%20healthcare%20professional&amp;text=One%20blood%20test%20used%20for,higher%20or%20lower%20than%20expected.\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.mayoclinic.org\/diseases-conditions\/myelofibrosis\/diagnosis-treatment\/<\/span><\/a><\/p>\n<p><a href=\"https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/tests-treatment\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.cancerresearchuk.org\/about-cancer\/myelofibrosis\/tests-treatment<\/span><\/a><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.msdmanuals.com\/professional\/hematology-and-oncology\/myeloproliferative-disorders\/primary-myelofibrosis-pmf\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">https:\/\/www.msdmanuals.com\/professional\/hematology-and-oncology\/myeloproliferative-disorders\/primary-myelofibrosis-pmf<\/span><\/a><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Myelofibrosis is a rare condition where the bone marrow&#8217;s capacity to produce blood cells is compromised. Its symptoms; such as fatigue, anemia, and enlarged spleen; can mimic other illnesses, making diagnosis particularly challenging. That\u2019s why understanding myelofibrosis; treatment, prevention &amp; management is essential for timely and accurate care.\u00a0 This guide provides a step-by-step breakdown of...","protected":false},"author":11,"featured_media":36453,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"class_list":["post-36474","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>How Is Myelofibrosis Diagnosed? A Step-by-Step Guide<\/title>\n<meta name=\"description\" content=\"Myelofibrosis is a rare condition where the bone marrow&#039;s capacity to produce blood cells is compromised.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide %\" \/>\n<meta property=\"og:description\" content=\"Myelofibrosis is a rare condition where the bone marrow&#039;s capacity to produce blood cells is compromised.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-01T13:53:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-22T06:51:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/08\/How-Is-Myelofibrosis-Diagnosed.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide","description":"Myelofibrosis is a rare condition where the bone marrow's capacity to produce blood cells is compromised.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/","og_locale":"en_US","og_type":"article","og_title":"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide %","og_description":"Myelofibrosis is a rare condition where the bone marrow's capacity to produce blood cells is compromised.","og_url":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-08-01T13:53:06+00:00","article_modified_time":"2025-09-22T06:51:27+00:00","og_image":[{"width":1024,"height":767,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/08\/How-Is-Myelofibrosis-Diagnosed.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide","datePublished":"2025-08-01T13:53:06+00:00","dateModified":"2025-09-22T06:51:27+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/"},"wordCount":1101,"commentCount":36,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/08\/How-Is-Myelofibrosis-Diagnosed.webp","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/","url":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/","name":"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/08\/How-Is-Myelofibrosis-Diagnosed.webp","datePublished":"2025-08-01T13:53:06+00:00","dateModified":"2025-09-22T06:51:27+00:00","description":"Myelofibrosis is a rare condition where the bone marrow's capacity to produce blood cells is compromised.","breadcrumb":{"@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/08\/How-Is-Myelofibrosis-Diagnosed.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/08\/How-Is-Myelofibrosis-Diagnosed.webp","width":1024,"height":767,"caption":"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/how-is-myelofibrosis-diagnosed-a-step-by-step-guide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"Blog","item":"https:\/\/massivebio.com\/blog-en\/"},{"@type":"ListItem","position":3,"name":"How Is Myelofibrosis Diagnosed? A Step-by-Step Guide"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=36474"}],"version-history":[{"count":2,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36474\/revisions"}],"predecessor-version":[{"id":37664,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36474\/revisions\/37664"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/36453"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=36474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=36474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=36474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}